Ecotypes of triple-negative breast cancer in response to chemotherapy

Study participant details from the ARTEMIS Trial The clinical trial protocol was reviewed and approved by The University of Texas MD Anderson Cancer Center Institutional Review Board and all participants provided written informed consent ( NCT02276443 ; MDA no. 2014-0185). All study procedures performed were in accordance with ethical standards of the Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. …